HANMIPHARM revenue breakdown overview

HANMIPHARM revenue for the last year amounted to 1.49 T KRW, the most of which — 1.09 T KRW — came from its highest performing source at the moment, Medicine, the year earlier bringing 975.02 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought HANMIPHARM 890.76 B KRW, and the year before that — 826.08 B KRW.